Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-20-004000
Filing Date
2020-11-17
Accepted
2020-11-17 17:27:18
Documents
68
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT 1 sonoma_10qa-063020.htm 10-Q/A 515670
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER sonoma_ex3101.htm EX-31.1 8438
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER sonoma_ex3102.htm EX-31.2 8147
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 4143
  Complete submission text file 0001683168-20-004000.txt   3939470

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE snoa-20200630.xml EX-101.INS 674820
6 XBRL SCHEMA FILE snoa-20200630.xsd EX-101.SCH 33240
7 XBRL CALCULATION FILE snoa-20200630_cal.xml EX-101.CAL 62622
8 XBRL DEFINITION FILE snoa-20200630_def.xml EX-101.DEF 150685
9 XBRL LABEL FILE snoa-20200630_lab.xml EX-101.LAB 276437
10 XBRL PRESENTATION FILE snoa-20200630_pre.xml EX-101.PRE 278392
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 001-33216 | Film No.: 201322135
SIC: 2834 Pharmaceutical Preparations